With the biotech space red-hot right now amid the race for solutions to the COVID-19 crisis, how can traders assess potential biotech plays? Noting that “biotechnology companies do not have traditional financial metrics”, the author of today’s article has “built a formula to help analyze them from a more potential based perspective” – and he shares this biotech valuation formula in a video. For more, CLICK HERE.